Luliconazole

CAS 187164-19-8

Visão geral

Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan

A Anant Labs fabrica e fornece impurezas de Luliconazole de alta qualidade para o mercado global. Nossas impurezas EP de Luliconazole são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Luliconazole

Cat. No. ANTPRD5110Old No. ANT-LCZ-06CAS 187164-19-8Consulte

Dados Técnicos

New Cat. No.ANTPRD5110

Old Cat. No.ANT-LCZ-06

CAS187164-19-8

Fórmula Mol.C₁₄H₉Cl₂N₃S₂

Peso Mol.354.287 g/mol

IUPAC(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile

SMILESC1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl

InChIInChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1

Chave InChIYTAOBBFIOAEMLL-REQDGWNSSA-N

Sinônimos

Luliconazole187164-19-8LuliconNND-502LuzuPR-2699NND502luliconazol(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrileDTXSID3048607